CARE EQUITY CAPITAL MANAGEMENT, L.P.
CARE EQUITY CAPITAL MANAGEMENT, L.P. is a Series C+ and buyout fund in the US investing in Healthcare, healthcare-tech, life-sciences and pharma.
- Stages
- Series C+, buyout
- Sectors
- Healthcare, healthcare-tech, life-sciences, pharma
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2020
- Assets under management
- $426.85M
- Website
- careequity.com
Check size not disclosed
Thesis
CARE EQUITY CAPITAL MANAGEMENT, L.P. (Care Equity), founded in 2020 and based in New York, is a Registered Investment Adviser (RIA) focused on the healthcare sector, particularly life sciences and care delivery ecosystems. The firm invests in companies that provide outsourced drug discovery and development services, supporting scientific teams with innovative solutions for biopharmaceutical sponsors. Care Equity targets high-value research and technology companies driving innovation and transforming healthcare payment models. Their investment strategy encompasses growth-stage, buyout, and platform funding transactions, primarily in private securities. The firm manages pooled investment vehicles, including Fund I and Fund II, with Fund I closing oversubscribed at $125 million in December 2020 against a $100 million target. Care Equity's geographic focus is on companies across the United States. As of March 31, 2026, their total regulatory assets under management (AUM) were approximately $426,850,000. They are primarily focused on Private Equity Funds.
Common questions
Does CARE EQUITY CAPITAL MANAGEMENT, L.P. invest at the Series C+ stage?
Yes. CARE EQUITY CAPITAL MANAGEMENT, L.P. lists Series C+ and buyout among the stages it invests in.
Where does CARE EQUITY CAPITAL MANAGEMENT, L.P. invest?
CARE EQUITY CAPITAL MANAGEMENT, L.P. invests in the US.